Back to Journals » Lung Cancer: Targets and Therapy » Volume 7

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

Total article views   HTML views PDF downloads Totals
9,359 Dovepress* 8,202+ 1,580 9,782
PubMed Central* 1,157 320 1,477
Totals 9,359 1,900 11,259
*Since 17 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar